Thursday, September 12, 2002 10:48:51 AM
BioShield Technologies Receives Extended Patent Approval From U.S. Patent Office on BioShield`s AM500 Antimicrobial; Secures a Broader Array of Claims And Potential Applications
September 12, 2002 10:10:00 (ET)
ATLANTA, Sep 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announces today that it has recently received from the U.S. Patent Office an approval extending BioShield's AM500 antimicrobial, securing the rights to a broader array of applications and formularies. This new patent approval helps to solidify BioShield's positioning in the coatings industry and various other industries to control the growth of bacteria, mold, mildew and algae for both indoor or outdoor applications. The final patent filing and respective claims are anticipated to be issued as a U.S. Registered Patent within the next few months.
Deirdre Baker, BioShield's General Manager stated, "this new Patent approval contributes a great deal to our competitive advantage, creates new barriers to entry for our competition to participate in the antimicrobial and antibacterial industries, and further enhances and protects BioShield's intellectual property portfolio. The approval of this Patent further solidifies BioShield's position in the antimicrobial industry as having one of the broadest product lines that provide the benefit of being essentially non- toxic, water-based, non-leaching and having long-term effectiveness. Over the past five years, BioShield has invested over $20 million in product research and development, EPA registrations and patent filings and this latest milestone is another great example of the value that is created with BioShield's technology foundation."
About BioShield Technologies, Inc.:
BioShield Technologies, Inc., is a Norcross Georgia based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizes, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Amelia Hale.
Safe Harbor/Forward-looking Statements:
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X73664717
SOURCE BioShield Technologies, Inc.
Amelia Hale of Bioshield Technologies, Inc., +1-770-925-3653
http://www.bioshield.com
Copyright (C) 2002 PR Newswire. All rights reserved.
The best weapon against "fear" is "facts"!!
September 12, 2002 10:10:00 (ET)
ATLANTA, Sep 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announces today that it has recently received from the U.S. Patent Office an approval extending BioShield's AM500 antimicrobial, securing the rights to a broader array of applications and formularies. This new patent approval helps to solidify BioShield's positioning in the coatings industry and various other industries to control the growth of bacteria, mold, mildew and algae for both indoor or outdoor applications. The final patent filing and respective claims are anticipated to be issued as a U.S. Registered Patent within the next few months.
Deirdre Baker, BioShield's General Manager stated, "this new Patent approval contributes a great deal to our competitive advantage, creates new barriers to entry for our competition to participate in the antimicrobial and antibacterial industries, and further enhances and protects BioShield's intellectual property portfolio. The approval of this Patent further solidifies BioShield's position in the antimicrobial industry as having one of the broadest product lines that provide the benefit of being essentially non- toxic, water-based, non-leaching and having long-term effectiveness. Over the past five years, BioShield has invested over $20 million in product research and development, EPA registrations and patent filings and this latest milestone is another great example of the value that is created with BioShield's technology foundation."
About BioShield Technologies, Inc.:
BioShield Technologies, Inc., is a Norcross Georgia based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizes, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Amelia Hale.
Safe Harbor/Forward-looking Statements:
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X73664717
SOURCE BioShield Technologies, Inc.
Amelia Hale of Bioshield Technologies, Inc., +1-770-925-3653
http://www.bioshield.com
Copyright (C) 2002 PR Newswire. All rights reserved.
The best weapon against "fear" is "facts"!!
The best weapon against "fear" is "facts"!!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
